Literature DB >> 19648117

Nutlin-3 affects expression and function of retinoblastoma protein: role of retinoblastoma protein in cellular response to nutlin-3.

Wei Du1, Junfeng Wu, Erica M Walsh, Yujun Zhang, Chang Yan Chen, Zhi-Xiong Jim Xiao.   

Abstract

The retinoblastoma protein (Rb) plays a pivotal role in regulating cell proliferation and apoptosis. Nutlin-3, a small molecule MDM2 antagonist blocking interaction between MDM2 and p53, activates p53 resulting in cell growth arrest or apoptosis in various cancer cells. However, the molecular basis for the different cellular responses upon nutlin-3 treatment is not fully understood. In this study, we show that nutlin-3 activates p53 resulting in a dramatic increase in MDM2 expression and a marked reduction in total Rb protein levels. Interestingly, nutlin-3 reduces the levels of hypophosphorylated Rb and induces massive apoptosis in SJSA-1 cells, which can be largely rescued by knockdown of MDM2 or by expression of constitutively active Rb. By contrast, nutlin-3 treatment of several human cancer cells, including A549, U2-OS, and HCT116, results in an accumulation of hypophosphorylated Rb and cell cycle arrest but not apoptosis. Furthermore, we show that down-regulation of Rb by nutlin-3 does not lead to E2F1 activation nor does E2F1 play a critical role for nutlin-3-induced apoptosis in SJSA-1 cells. Taken together, these results suggest that Rb plays a critical role in influencing cellular response to activation of p53 pathway by nutlin-3.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648117      PMCID: PMC2785319          DOI: 10.1074/jbc.M109.046904

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  RB regulates the stability and the apoptotic function of p53 via MDM2.

Authors:  J K Hsieh; F S Chan; D J O'Connor; S Mittnacht; S Zhong; X Lu
Journal:  Mol Cell       Date:  1999-02       Impact factor: 17.970

3.  Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation.

Authors:  Chiharu Uchida; Seiichi Miwa; Kyoko Kitagawa; Takayuki Hattori; Tomoyasu Isobe; Sunao Otani; Toshiaki Oda; Haruhiko Sugimura; Takehiko Kamijo; Keizou Ookawa; Hideyo Yasuda; Masatoshi Kitagawa
Journal:  EMBO J       Date:  2004-12-02       Impact factor: 11.598

4.  Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression.

Authors:  E S Knudsen; C Buckmaster; T T Chen; J R Feramisco; J Y Wang
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

Review 5.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

6.  Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.

Authors:  J Wang; A Sampath; P Raychaudhuri; S Bagchi
Journal:  Oncogene       Date:  2001-08-02       Impact factor: 9.867

7.  The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.

Authors:  Patima Sdek; Haoqiang Ying; Hongwu Zheng; Alexander Margulis; Xiaoren Tang; Kui Tian; Zhi-Xiong Jim Xiao
Journal:  J Biol Chem       Date:  2004-10-13       Impact factor: 5.157

8.  Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors.

Authors:  Daisy Carvajal; Christian Tovar; Hong Yang; Binh T Vu; David C Heimbrook; Lyubomir T Vassilev
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

9.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

Review 10.  The yin and yang of E2F-1: balancing life and death.

Authors:  Nicholas B La Thangue
Journal:  Nat Cell Biol       Date:  2003-07       Impact factor: 28.824

View more
  15 in total

1.  Nutlin-3 down-regulates retinoblastoma protein expression and inhibits muscle cell differentiation.

Authors:  Erica M Walsh; MengMeng Niu; Johann Bergholz; Zhi-Xiong Jim Xiao
Journal:  Biochem Biophys Res Commun       Date:  2015-04-12       Impact factor: 3.575

2.  Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia.

Authors:  Jianting Long; Brian Parkin; Peter Ouillette; Dale Bixby; Kerby Shedden; Harry Erba; Shaomeng Wang; Sami N Malek
Journal:  Blood       Date:  2010-04-19       Impact factor: 22.113

Review 3.  The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression.

Authors:  Jiandong Chen
Journal:  Cold Spring Harb Perspect Med       Date:  2016-03-01       Impact factor: 6.915

4.  C1 Domain-targeted isophthalate derivatives induce cell elongation and cell cycle arrest in HeLa cells.

Authors:  Virpi Talman; Raimo K Tuominen; Gustav Boije af Gennäs; Gustav Boije Af Gennäs; Jari Yli-Kauhaluoma; Elina Ekokoski
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

5.  Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblasts.

Authors:  Kristiaan Lenos; Job de Lange; Amina F A S Teunisse; Kirsten Lodder; Matty Verlaan-de Vries; Eliza Wiercinska; Marja J M van der Burg; Karoly Szuhai; Aart G Jochemsen
Journal:  Mol Cancer       Date:  2011-09-12       Impact factor: 27.401

6.  Constitutional Nephrin Deficiency in Conditionally Immortalized Human Podocytes Induced Epithelial-Mesenchymal Transition, Supported by β-Catenin/NF-kappa B Activation: A Consequence of Cell Junction Impairment?

Authors:  Gian Marco Ghiggeri; Maddalena Gigante; Armando Di Donato
Journal:  Int J Nephrol       Date:  2013-11-24

Review 7.  Roles of pRB in the Regulation of Nucleosome and Chromatin Structures.

Authors:  Chiharu Uchida
Journal:  Biomed Res Int       Date:  2016-12-22       Impact factor: 3.411

8.  Rapamycin inhibits IGF-1-mediated up-regulation of MDM2 and sensitizes cancer cells to chemotherapy.

Authors:  Wei Du; Yong Yi; Haibo Zhang; Johann Bergholz; Junfeng Wu; Haoqiang Ying; Yujun Zhang; Zhi-Xiong Jim Xiao
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

9.  Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma.

Authors:  Sushma Kalmodia; Sowmya Parameswaran; Kalaivani Ganapathy; Wenrong Yang; Colin J Barrow; Jagat R Kanwar; Kislay Roy; Madavan Vasudevan; Kirti Kulkarni; Sailaja V Elchuri; Subramanian Krishnakumar
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-20

10.  p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.

Authors:  Manikandan Periyasamy; Anup K Singh; Carolina Gemma; Christian Kranjec; Raed Farzan; Damien A Leach; Naveenan Navaratnam; Hajnalka L Pálinkás; Beata G Vértessy; Tim R Fenton; John Doorbar; Frances Fuller-Pace; David W Meek; R Charles Coombes; Laki Buluwela; Simak Ali
Journal:  Nucleic Acids Res       Date:  2017-11-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.